Neuren Pharmaceuticals Limited NURPF
NURPF
Neuren Pharmaceuticals Limited MOLN
Molecular Partners AG MNOV
MediciNova, Inc. ANEB
Anebulo Pharmaceuticals, Inc. CSBR
Champions Oncology, Inc. CYT
Cyteir Therapeutics, Inc. AVTE
Aerovate Therapeutics, Inc. ELVN
Enliven Therapeutics, Inc. MLTX
MoonLake Immunotherapeutics GPCR
Structure Therapeutics Inc.
Neuren Pharmaceuticals Limited MOLN
Molecular Partners AG MNOV
MediciNova, Inc. ANEB
Anebulo Pharmaceuticals, Inc. CSBR
Champions Oncology, Inc. CYT
Cyteir Therapeutics, Inc. AVTE
Aerovate Therapeutics, Inc. ELVN
Enliven Therapeutics, Inc. MLTX
MoonLake Immunotherapeutics GPCR
Structure Therapeutics Inc.
Performance
| Periode | NURPF | MOLN | MNOV | ANEB | CSBR | CYT | AVTE | ELVN | MLTX | GPCR |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 46.25 % | 21.23 % | -5.15 % | -20.00 % | -8.35 % | -1.63 % | -97.09 % | -21.62 % | -69.62 % | 210.95 % |
| YTD | 70.21 % | -10.88 % | -39.44 % | -24.05 % | -13.05 % | 0.00 % | -97.15 % | -30.61 % | -74.05 % | 146.86 % |
| 1Y | 63.72 % | -18.27 % | -37.68 % | -25.93 % | -9.40 % | 55.68 % | -99.52 % | -28.36 % | -73.61 % | 146.34 % |
| 3Y | 154.39 % | -30.49 % | -36.14 % | -52.19 % | 56.36 % | -82.64 % | -99.37 % | 2.88 % | 42.56 % | 167.65 % |
| 5Y | 1 242.19 % | -77.91 % | -77.09 % | -83.10 % | -36.23 % | -82.64 % | -99.66 % | -81.17 % | 26.13 % | 167.65 % |
| 10Y | -62.10 % | -77.91 % | -62.93 % | -83.10 % | 80.51 % | -82.64 % | -99.66 % | -72.36 % | 32.51 % | 167.65 % |
| Depuis le début | -90.24 % | -77.91 % | -88.22 % | -83.10 % | -0.97 % | -82.64 % | -99.66 % | -72.36 % | 32.51 % | 167.65 % |